Back
HFA Premium Access

Efficacy of ARNI in patients using LVAD: a systematic review and meta-analysis

Session: Pharmacology and pharmacotherapy
Topic: Angiotensin-Renin-Bradykinin System
Speaker: Doctor E. Hasabo (Galway, IE)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Elfatih A Hasabo

Galway (Ireland)
0 follower

5 more presentations in this session

Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report

Speaker: Doctor M. Feola (Mondovi, IT)

Access
Abstract
Slides
Like
Thumbnail

Real-life adverse events with SGLT-2 inhibitors: different safety profiles according to their indications?

Speaker: Mr O. Chebbo (Montpellier, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Assessing doctors' knowledge and confidence regarding SGLT2 inhibitor prescribing practices, side-effects, and ESC guidelines

Speaker: Doctor E. Higgisson (Dublin, IE)

Access
Abstract
Slides
Video
Like
Thumbnail

Intravenous iron therapy for patients with heart failure and iron deficiency: an updated meta-analysis of randomized controlled trials

Speaker: Mr G. Yeap (GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy and safety of SGLT2-i in patients using LVAD: a systematic review and meta-analysis

Speaker: Doctor E. Hasabo (Galway, IE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Pharmacology and pharmacotherapy

Speakers: Doctor E. Hasabo, Doctor M. Feola, Mr O. Chebbo, Doctor E. Higgisson, Mr G. Yeap...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources